“…Several studies from our group and others have demonstrated increased microglial activation, TNFα and/or IL-1β levels in the prefrontal cortex, hippocampus, amygdala and hypothalamus (Borre et al, 2012, Myint et al, 2007, Burke et al, 2013a and neurodegeneration in the amygdala and hippocampus (Wrynn et al, 2000, Jarosik et al, 2007 of OB rats. The antidepressant-like effect of minocycline in OB rats is associated with an attenuation of increases in oxidative-nitrosative stress markers, TNFα and IL-6 levels and caspase 3 activity in the cortex and hippocampus (Rinwa and Kumar, 2013). Thus, minocycline may modulate microglial activation and neuronal reorganisation that occurs in response to removal of the bulbs, mitigating some of the pathological alterations observed in the model and resulting in an antidepressant-like effect.…”